Live Breaking News & Updates on Selective Sphingosine

Stay updated with breaking news from Selective sphingosine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Clinical Overview: Etrasimod for Ulcerative Colitis

Etrasimod is an advanced synthetic compound classified as a selective modulator of Sphingosine 1-phosphate (S1P) receptors, specifically targeting S1P1, S1P4, and S1P5 receptors . ....

New York , United States , Pfizer Inc , Severely Active Ulcerative Colitis , Accessed October , Selective Sphingosine , Alleviates Experimental ,